Article Text

Does CT scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis?
Free
  1. S de Boer1,
  2. D G Milne2,
  3. I Zeng1,
  4. M L Wilsher1
  1. 1
    Green Lane Respiratory Services, Auckland City Hospital, Auckland District Health Board, Auckland, New Zealand
  2. 2
    Department of Radiology, Auckland City Hospital, Auckland District Health Board, Auckland, New Zealand
  1. Dr S de Boer, Green Lane Respiratory Services, Auckland City Hospital, Private Bag 92 024, Auckland 01, New Zealand; sdeboer{at}adhb.govt.nz

Abstract

Background: Transbronchial lung biopsy (TBB) has a variable diagnostic yield in sarcoidosis. It was hypothesised that the extent and pattern of parenchymal disease on CT scanning would predict the likelihood of a positive TBB result.

Methods: Patients with sarcoidosis (n = 77) were included if they had undergone a CT scan within 6 weeks of TBB. Ethnicity, symptoms, pulmonary function and site and results of TBB and bronchoalveolar lavage (BAL) were recorded. CT scans were scored quantitatively for patterns of parenchymal disease (nodular, reticular, consolidation and ground glass) on a lobar basis.

Results: 39 patients (50.6%) had a positive TBB. Symptoms, ethnicity, treatment, lung volumes and chest radiographic stage were not predictors of a positive biopsy. Female gender, reduced percentage predicted carbon monoxide transfer factor and a higher percentage of lymphocytes in the BAL fluid were associated with a positive biopsy, as were higher total lung score, reticular pattern and ground-glass opacity. The associations were more significant for the total lobar score and the lobar ground-glass score of the lobe biopsied. On multivariate analysis gender, percentage of lymphocytes in the BAL fluid and total lung score were independent predictors of a positive TBB.

Conclusion: The total extent of parenchymal disease on the CT scan in addition to the pattern and lobar distribution predicts the likelihood of a positive TBB at bronchoscopy.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Supplementary materials

Footnotes

  • Table 5 is published online only at http://thorax.bmj.com/content/vol64/issue5

  • Funding: Supported by a grant from the Myrtle Martin Trust.

  • Competing interests: None.

  • Ethics approval: The study received approval from the New Zealand Ministry of Health northern regional ethics committee.